Prudential plc’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,098
Closed -$270K 927
2022
Q3
$270K Buy
1,098
+113
+11% +$30.5K ﹤0.01% 738
2022
Q2
$244K Buy
985
+75
+8% +$20.2K ﹤0.01% 747
2022
Q1
$301K Buy
+910
New +$280K ﹤0.01% 729
2021
Q1
Sell
-3,158
Closed -$1.02M 675
2020
Q4
$1.02M Hold
3,158
0.01% 459
2020
Q3
$875K Sell
3,158
-283
-8% -$81.5K ﹤0.01% 444
2020
Q2
$831K Buy
+3,441
New +$691K ﹤0.01% 435
2018
Q4
Sell
-667
Closed -$300K 742
2018
Q3
$300K Buy
+667
New +$263K ﹤0.01% 615

Other funds holding ABMD

Prudential plc's ABMD Position: Q4 2022 in Review

Prudential plc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,098 shares — an estimated $270K sold.

Prudential plc first reported a position in ABMD in Q3 2018 and held it in 7 quarters. The position peaked at $1.02M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Prudential plc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Prudential plc sold 1,098 Abiomed Inc shares in Q4 2022, an estimated $270K.
  • Prudential plc first reported a position in Abiomed Inc in Q3 2018 and held it in 7 quarters.
  • Prudential plc's Abiomed Inc position peaked at $1.02M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Prudential plc's 13F filing for Q4 2022, filed 9 Feb 2023.